4th Quarter - Report
STANTON PARK GROUP for BRAEBURN PHARMACEUTICALS, INC.
Firm
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reducing stigma and promoting treatment of opioid use disorder; raising awareness of the benefits of medication assisted therapy (MAT); ensuring patient access to MAT; FDA approval and exclusivity process; patient access to practitioner-administered therapies Reauthorization of the Support Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES DERDERIAN | Chief of Staff, House Commerce Committee; Legislative Advisor to Rep. Tom Bliley |
| VALERIE HENRY | Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo |
| JOSEPH RACHINSKY | — |
| BRYAN WILLIAM WELLS New | Policy Advisor, Senator Pat Roberts |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.